Subjects: SINAIS E SINTOMAS, MANIFESTAÇÕES CUTÂNEAS, QUALIDADE DE VIDA
ABNT
OLSEN, Elise A. et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, v. 140, n. 5, p. 419-437, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50496. Acesso em: 16 nov. 2024.APA
Olsen, E. A., Whittaker, S., Willemze, R., Pinter-brown, L., Foss, F., Geskin, L., et al. (2022). Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, 140( 5), 419-437. doi:10.1182/blood.2021012057NLM
Olsen EA, Whittaker S, Willemze R, Pinter-brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [Internet]. Blood. 2022 ; 140( 5): 419-437.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50496Vancouver
Olsen EA, Whittaker S, Willemze R, Pinter-brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC [Internet]. Blood. 2022 ; 140( 5): 419-437.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50496